Skip to content

Precision Fecal microbiota transplantation donor-recipient mating in autism with concomitant digestive symptoms and quantitative evaluation of post-transplant flora remodeling

Precision Fecal microbiota transplantation donor-recipient mating in autism with concomitant digestive symptoms and quantitative evaluation of post-transplant flora remodeling

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105006
Enrollment
Unknown
Registered
2025-06-26
Start date
2025-02-25
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorders

Interventions

FMT:The intervention in this study was a new medical technology, enterobacterial transplantation (FMT), and the treatment protocol involved multiple cours

Sponsors

Zhongnan Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age 3 years or older; 2.diagnosis of autism spectrum disorder (ASD) according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-V); 3.accompanying gastrointestinal symptoms; 4.disturbed intestinal flora as indicated by intestinal flora testing; 5.agreement to participate in the study by the patient or his/her guardian and signing of the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Severe gastrointestinal symptoms or organic disease requiring immediate surgery or treatment; 2.Recent antibiotic or probiotic use: antibiotics in the past 1 month, probiotics in the past 1 week; 3.Other organic dysfunction, such as cerebral palsy, congenital genetic disorders; 4.History of other psycho-behavioural disorders other than those in the neurodevelopmental disorders category, inherited metabolic disorders, and other major somatic disorders; 5.Other: any investigator Factors that, in the opinion of the researcher, may influence the results of the study;

Design outcomes

Primary

MeasureTime frame
Clinical improvement;

Secondary

MeasureTime frame
Assessment of gastrointestinal symptoms;Microbiota and their metabolite changes;Improvement in quality of life;

Countries

China

Contacts

Public ContactJingyi Fan

Zhongnan Hospital of Wuhan University

wumerfan@126.com+86 189 7114 4815

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026